Loss of CNS IL-2 gene expression modifies brain T lymphocyte trafficking: Response of normal versus autoreactive Treg-deficient T cells

Neuroscience Letters

Volumn 499, Issue 3, 2011, Pages 213-218

  Huang, Zhi ^a   Meola, Danielle ^a   Petitto, John M ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Autoimmunity; Brain; Congenic mice; Gene deletion; IL 2; Neuroimmunology; T cells

Indexed keywords

INTERLEUKIN 2;

ARTICLE; AUTOIMMUNITY; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; GENE EXPRESSION; GENE INACTIVATION; HIPPOCAMPUS; MOUSE; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLENOMEGALY; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; CELL MOVEMENT; CEREBELLUM; GENE EXPRESSION; HIPPOCAMPUS; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEUROIMMUNOMODULATION; SEPTUM OF BRAIN; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 79960093224     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.05.230     Document Type: Article

References (46)

1. Araujo D.M., Lapchak P.A., Chabot J.G., Nair N.P., Quirion R. Characterization and possible role of growth factor and lymphokine receptors in the regulation of cholinergic function in the mammalian brain. Prog. Clin. Biol. Res. 1989, 317:423-436.
2. Babcock A.A., Kuziel W.A., Rivest S., Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 2003, 23:7922-7930.
3. Beck R.D., King M.A., Ha G.K., Cushman J.D., Huang Z., Petitto J.M. IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins. J. Neuroimmunol. 2005, 160:146-153.
4. Beck R.D., King M.A., Huang Z., Petitto J.M. Alterations in septohippocampal cholinergic neurons resulting from interleukin-2 gene knockout. Brain Res. 2002, 955:16-23.
5. Beck R.D., Wasserfall C., Ha G.K., Cushman J.D., Huang Z., Atkinson M.A., Petitto J.M. Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice. Brain Res. 2005, 1041:223-230.
6. Cardona A.E, Li M., Liu L., Savarin C., Ransohoff R.M. Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J. Leukoc. Biol. 2008, 84:587-594.
7. Cose S., Brammer C., Khanna K.M., Masopust D., Lefrancois L. Evidence that a significant number of naive T cells enter non-lymphoid organs as part of a normal migratory pathway. Eur. J. Immunol. 2006, 36:1423-1433.
8. Ellis T.M., Atkinson M.A. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nat. Med. 1996, 2:148-153.
9. Fatemi S.H., Halt A.R., Stary J.M., Kanodia R., Schulz S.C., Realmuto G.R. Glutamic acid decarboxylase 65 and 67kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 2002, 52:805-810.
10. Flugel A., Hager G., Horvat A., Spitzer C., Singer G.M., Graeber M.B., Kreutzberg G.W., Schwaiger F.W. Neuronal MCP-1 expression in response to remote nerve injury. J. Cereb. Blood Flow Metab. 2001, 21:69-76.
11. Gomez-Nicola D., Valle-Argos B., Nieto-Sampedro M. Blockade of IL-15 activity inhibits microglial activation through the NFkappaB, p38, and ERK1/2 pathways, reducing cytokine and chemokine release. Glia 2010, 58:264-276.
12. Hanisch U.K., Quirion R. Interleukin-2 as a neuroregulatory cytokine. Brain Res. Brain Res. Rev. 1995, 21:246-284.
13. Hanisch U.K., Seto D., Quirion R. Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2. J. Neurosci. 1993, 13:3368-3374.
14. Hickey W.F., Hsu B.L., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 1991, 28:254-260.
15. Horak I., Lohler J., Ma A., Smith K.A. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol. Rev. 1995, 148:35-44.
16. Huang Z., Dauer D.J., Ha G.K., Lewis M.H., Petitto J.M. Interleukin-2 deficiency-induced T cell autoimmunity in the mouse brain. Neurosci. Lett. 2009, 463:44-48.
17. Huang Z., Ha G.K., Petitto J.M. IL-15 and IL-15R alpha gene deletion: effects on T lymphocyte trafficking and the microglial and neuronal responses to facial nerve axotomy. Neurosci. Lett. 2007, 417:160-164.
18. Kundig T.M., Schorle H., Bachmann M.F., Hengartner H., Zinkernagel R.M., Horak I. Immune responses in interleukin-2-deficient mice. Science 1993, 262:1059-1061.
19. Lapchak P.A., Araujo D.M., Quirion R., Beaudet A. Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neuroscience 1991, 44:173-184.
20. Malek T.R., Yu A., Zhu L., Matsutani T., Adeegbe D., Bayer A.L. IL-2 family of cytokines in T regulatory cell development and homeostasis. J. Clin. Immunol. 2008, 28:635-639.
21. Martino G., Hartung H.P. Immunopathogenesis of multiple sclerosis: the role of T cells. Curr. Opin. Neurol. 1999, 12:309-321.
22. Pan W., Yu C., Hsuchou H., Khan R.S., Kastin A.J. Cerebral microvascular IL-15 is a novel mediator of TNF action. J. Neurochem. 2009, 111:819-827.
23. Petitto J.M., Huang Z. Cloning the full-length IL-2/15 receptor-beta cDNA sequence from mouse brain: evidence of enrichment in hippocampal formation neurons. Regul. Pept. 2001, 98:77-87.
24. Petitto J.M., Huang Z. Molecular cloning of the coding sequence of an interleukin-2 receptor alpha subunit cDNA in murine brain. J. Neuroimmunol. 1995, 59:135-141.
25. Petitto J.M., Huang Z., Lo J., Beck R.D., Rinker C., Hartemink D.A. Relationship between the development of autoimmunity and sensorimotor gating in MRL-lpr mice with reduced IL-2 production. Neurosci. Lett. 2002, 328:304-308.
26. Petitto J.M., Huang Z., Lo J., Streit W.J. IL-2 gene knockout affects T lymphocyte trafficking and the microglial response to regenerating facial motor neurons. J. Neuroimmunol. 2003, 134:95-103.
27. Petitto J.M., Huang Z., Raizada M.K., Rinker C.M., McCarthy D.B. Molecular cloning of the cDNA coding sequence of IL-2 receptor-gamma (gammac) from human and murine forebrain: expression in the hippocampus in situ and by brain cells in vitro. Brain Res. Mol. Brain Res. 1998, 53:152-162.
28. Petitto J.M., McNamara R.K., Gendreau P.L., Huang Z., Jackson A.J. Impaired learning and memory and altered hippocampal neurodevelopment resulting from interleukin-2 gene deletion. J. Neurosci. Res. 1999, 56:441-446.
29. Quirion R., Aubert I., Robitaille Y., Gauthier S., Araujo D.M., Chabot J.G. Neurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies. Clin. Neuropharmacol. 1990, 13(Suppl. 3):S73-S80.
30. Ramirez-Montealegre D., Chattopadhyay S., Curran T.M., Wasserfall C., Pritchard L., Schatz D., Petitto J., Hopkins D., She J.X., Rothberg P.G., Atkinson M., Pearce D.A. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Neurology 2005, 64:743-745.
31. Ransohoff R.M. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 2009, 31:711-721.
32. Schorle H., Holtschke T., Hunig T., Schimpl A., Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991, 352:621-624.
33. Seto D., Kar S., Quirion R. Evidence for direct and indirect mechanisms in the potent modulatory action of interleukin-2 on the release of acetylcholine in rat hippocampal slices. Br. J. Pharmacol. 1997, 120:1151-1157.
34. Sgouroudis E., Albanese A., Piccirillo C.A. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice. J. Immunol. 2008, 181:6283-6292.
35. Sharma R., Fu S.M., Ju S.T. IL-2: a two-faced master regulator of autoimmunity. J. Autoimmun. 2011, 36:91-97.
36. Sharma R., Ju A.C., Kung J.T., Fu S.M., Ju S.T. Rapid and selective expansion of nonclonotypic T cells in regulatory T cell-deficient, foreign antigen-specific TCR-transgenic scurfy mice: antigen-dependent expansion and TCR analysis. J. Immunol. 2008, 181:6934-6941.
37. Shi L, Smith S.E., Malkova N., Tse D., Su Y., Patterson P.H. Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav. Immun. 2009, 23:116-123.
38. Turka L.A., Walsh P.T. IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells. Front. Biosci. 2008, 13:1440-1446.
39. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57:67-81.
40. Vogt J., Paul F., Aktas O., Muller-Wielsch K., Dorr J., Dorr S., Bharathi B.S., Glumm R., Schmitz C., Steinbusch H., Raine C.S., Tsokos M., Nitsch R., Zipp F. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann. Neurol. 2009, 66:310-322.
41. Wilkinson P.C., Liew F.Y. Chemoattraction of human blood T lymphocytes by interleukin-15. J. Exp. Med. 1995, 181:1255-1259.
42. Wu X., Pan W., He Y., Hsuchou H., Kastin A.J. Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2010, 223:65-72.
43. Yip J., Soghomonian J.J., Blatt G.J. Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study. Autism Res. 2009, 2:50-59.
44. Yip J., Soghomonian J.J., Blatt G.J. Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol. (Berl.) 2007, 113:559-568.
45. Zalcman S., Green-Johnson J.M., Murray L., Nance D.M., Dyck D., Anisman H., Greenberg A.H. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 1994, 643:40-49.
46. Zalcman S.S. Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists. Brain Res. 2002, 944:157-164.